L1PA.F LEE S PHARMACEUTIC.HD-05

Healthcare Pharmaceuticals Frankfurt Exchange
0.1184 EUR
Close of Nov 12, 2026
0.1008 0.1817
Market cap
EUR 69.7M
P/E
5.6x
P/B
0.28x
ROE
4.5%
Dividend yield
6.98%
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is L1PA.F undervalued?

Graham number

The Graham number of LEE S PHARMACEUTIC.HD-05 cannot be estimated reliably (the estimate is too far from the market price).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

LEE S PHARMACEUTIC.HD-05 fundamental analysis

No fundamental analysis for LEE S PHARMACEUTIC.HD-05 yet.

LEE S PHARMACEUTIC.HD-05 stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About LEE S PHARMACEUTIC.HD-05

Lee's Pharmaceutical Holdings Limited, an investment holding company, develops, manufactures, markets, and sells pharmaceutical products in the People's Republic of China, Hong Kong, and internationally. It focuses on various disease areas, such as cardiovascular, woman's health, pediatrics, rare diseases, oncology, dermatology, and obstetrics. It operates in Proprietary and Generic Products; and Licensed-In Products segments. The Proprietary and Generic Products segment man…

Full company profile